RecruitingNCT04310787

Long-term Prognosis of Patients With Hepatitis B Related Acute-on-chronic Liver Failure

The Investigation on Long-term Outcomes and Prognostic Factors of Patients With Hepatitis B Related Acute-on-chronic Liver Failure

Sponsor

Third Affiliated Hospital, Sun Yat-Sen University

Enrollment

300 participants

Start Date

May 15, 2020

Study Type

OBSERVATIONAL

Conditions

Hepatitis B Acute-On-Chronic Liver Failure

Summary

This study is to investigate the long-term outcomes and prognostic risk factors in patients recovered from hepatitis B virus related acute on-chronic liver failure.

Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria4

Age from 18 to 65 years old;
The diagnosis consistent with hepatitis b associated chronic acute liver failure；
After hospitalization, the survival time > 90 days；
The inpatient clinical data are complete.

Exclusion Criteria3

Human immunodeficiency virus infection or congenital immune deficiency diseases;
Liver cancer and other tumors, autoimmune liver disease, genetic and metabolic liver disease, or other serious diseases that significantly affect patient survival;
Other conditions that the researchers judged not appropriate for inclusion.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

Third Affiliated Hospital of Sun Yat-sen University

Guangzhou, Guangdong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04310787

Related Trials

Evaluation of Patients With Liver Disease

NCT000019711 location

Creation of a Cohort for the Quantitation and Characterization of Circulating Viral RNAs as a New Biomarker of Hepatitis B Functional Cure.

NCT038254586 locations